Navigation Links
Arsenal Capital Partners Announces the Acquisition of Western Institutional Review Board
Date:3/1/2012

NEW YORK, March 1, 2012 /PRNewswire/ -- Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle market healthcare, specialty industrial, and financial services companies, announced today the acquisition of Western Institutional Review Board (WIRB), a provider of information-based services which play an integral role in the clinical trial process for new drugs and medical devices.

WIRB is the leading independent institutional review board (IRB) services provider which operates federally mandated IRB panels.  IRBs review and approve the handling of ethical issues in research protocols before research involving human subjects can begin.  WIRB pioneered the concept of an independent IRB and is currently recognized as the "gold standard" in the industry.  The company has offices in the US and Canada and provides review services to research institutions, CROs and major sponsors in all 50 states and in more than 60 countries around the world. 

Stephen McLean, a Partner at Arsenal and Head of the firm's Healthcare Group, said, "We are delighted to invest in this important company.  WIRB has a long standing reputation of applying best practices in protecting human subjects involved in clinical research. Our investment in WIRB affords us the opportunity to apply Arsenal's unique healthcare industry resources to enhance and extend the essential IRB capabilities WIRB provides its clients."

"After evaluating a number of other options, we chose Arsenal Capital as our partners in creating the next chapter of our evolution.  We were impressed with Arsenal's expertise and capabilities in supporting our company's growth in the U.S. and globally. This is an extraordinarily positive development for our employees, our clients, and for the human subjects we protect," said Dudley Slater, CEO of WIRB.

Dr. Donald A. Deieso, Operating Partner in Arsenal's Healthcare Group will become Executive Chairman of WIRB.  Dr. Deieso commented, "The globalization of clinical research has created a number of new challenges for protecting human subjects.  WIRB will draw upon its longstanding knowledge of regulations and ethical practices to address these exciting challenges."

About Arsenal Capital Partners
Arsenal Capital Partners is a leading New York-based private equity firm that invests in middle market specialty industrial, healthcare and financial services companies.  Arsenal makes investments in sectors where the firm has significant prior knowledge and experience.  Arsenal targets businesses that have the potential for further value creation by working closely with management to accelerate growth and leverage the firm's operational improvement capabilities.  Arsenal currently has $800 million of committed equity capital.  For additional information on Arsenal Capital Partners, please visit www.arsenalcapital.com.

About Western Institutional Review Board
WIRB was founded in 1968 and is the leading provider of independent IRB, biosafety and other human protection services to the research institutions, CROs and major sponsors. The company has offices in the US and Canada and provides review services in all 50 states and in more than 60 countries around the world. For additional information on WIRB, please visit www.wirb.com.

Contact: Chris Tofalli
Chris Tofalli Public Relations, LLC
914-834-4334

WIRB Contact
Monika Roberts
360-252-2564
mroberts@wirb.com


'/>"/>
SOURCE Arsenal Capital Partners
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. bioMerieux Adds Methicillin-resistant Staphylococcus aureus (MRSA) Screening Tool to its Arsenal
2. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
3. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
4. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
5. Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials
6. Foundation Venture Capital Group Invests in UMDNJ Company Working to Improve Leukemia Treatments
7. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
8. Atlanta-based Med Tech Company CardioMEMS Raises Additional Capital to Advance its CHAMPION Clinical Trial for its Wireless Sensor System for Heart Failure Monitoring
9. Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million
10. Baxa Addresses Health-System Capital Shortage With New Programs for IntelliFlowRx(TM) and IntelliFill i.v.(R)
11. New Fall Allergy Capitals(TM) Reveal the Most Challenging Cities for Allergy Sufferers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... -- Acute, Chronic and Prophylaxis GVHD The global ... of 7% from 2016-2021 and CAGR of 3% from 2021-2027. The market ... 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, ... How ... can exploit the future business opportunities emerging in this sector. ...
(Date:2/19/2017)... , February 18, 2017 Marapharm ... to purchase a Medical Delivery Service with the specific ... transactions between qualified patients and caregivers. The delivery service ... located in the Coachella Valley, California ... Los Angeles area to the West, population ...
(Date:2/18/2017)... Feb. 17, 2017 Research and Markets has announced ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
Breaking Medicine Technology:
(Date:2/19/2017)... Warwick, RI (PRWEB) , ... February 19, 2017 ... ... data is proven to result in better care, and MEDfx and the Delaware ... the state of Delaware. , As the nation’s first state-wide health information exchange, ...
(Date:2/18/2017)... ... February 17, 2017 , ... ... Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, March 1, 2017 — ... looking to reduce their regulatory burden? Pay dividends in enhanced and predictable ...
(Date:2/18/2017)... Lewisberry, PA (PRWEB) , ... February 17, 2017 , ... ... more about the Stannah Stairlift and other Butler products. Ken was impressed with ... team, and agreed to endorse the product on his show. This endorsement by ...
(Date:2/18/2017)... ... February 17, 2017 , ... Park Cities Pet Sitter President, Joette White, has ... Life Radio network. The episode, which was posted this week, features a 30-minute ... led to Park Cities Pet Sitter’s being awarded the 2017 National Association of Professional ...
(Date:2/18/2017)... La. (PRWEB) , ... February 18, 2017 , ... ... released today provides the latest information and contact points to easily connect elderly ... home care, assisted living, and elder-care funding. It also conveys material on this ...
Breaking Medicine News(10 mins):